EUPRAXIA PHARMACEUTICALS INC. Operating Cash Flow
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Operating Cash Flow of -$28.55 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-03-13
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$28.55M 40-F · filed 2026-03-13 | |
| 2024-12-31 | -$29.99M 40-F · filed 2026-03-13 | |
| 2023-12-31 | -$20.75M 40-F · filed 2025-03-20 | -$20.68M 40-F · filed 2024-04-01 |
| 2022-12-31 | -$14.40M 40-F · filed 2024-04-01 |